Our findings support a model where basal insulin production and the capability of exocytosis are enhanced in T2D beta cells, but the stimulus-secretion coupling of insulin release and degradation of peptides that failed quality control are perturbed. The gene discussed is INS; the disease is type 2 diabetes mellitus.